WHEN: October 3-4 2016
WHERE: La Jolla, San Diego, CA
Global Engage is pleased to announce the 4th Microbiome R&D and Business Collaboration Forum: USA which will be held on 3-4 October 2016 at the San Diego Marriott La Jolla and co-located with the Probiotic Congress: USA.
Recent research has demonstrated the importance of our microbes in our maintaining health and their possible use in treating and preventing disease. As microbial dysbiosis has been shown to be linked to several long-term diseases; approaches that modify our microbiome by adding or removing individual microbes or entire microbial communities have been shown to have a significant impact on the health of an individual. This potential to use the microbiome as a therapy and to design treatments customised to the patient’s microbiome has created a rapidly growing interest from the pharmaceutical industry and investors and it looks set to continue to grow in the coming years with the emerging microbiome market expected to reach US$658 million by 2023. There is a rich source of information, backing and partnering opportunities for researchers and companies looking for opportunities in this field.
Attracting over 275 attendees, the 9th meeting in the global series will build upon the success of last year’s US meeting as well as our highly popular European and Asia forums to explore the interface between our evolving cultures, technologies and our microbiome through a series of interactive presentations and panel discussions with leading academics and industry experts as well as venture capital investors and leading solution, service and technology providers. The Global Engage series is rapidly gaining a fantastic reputation for fostering partnerships across academia, pharma and biotech. If looking to either learn more from the top scientists in the microbiome space; showcase exciting developments in your research; or seek partnerships and funding within the industry; it is a congress not to be missed.
The 2-day congress will examine a range of topics including:
- Host-microbe interactions
- Microbiome in health and disease
- Pharmaceutical involvement and translational microbiome studies
- Venture capital investment and collaborations
- Probiotics, prebiotics, diet and the microbiome
- Skin, respiratory, vaginal and oral microbiota research and therapeutic development
- Co-located probiotics congress